Evaluation of 2012 Bowel Cancer Awareness and Early Diagnosis Campaign at a District General Hospital
Poster Apr 22, 2013
M Alkhusheh, H Asalieh, N Smith
Be Clear on Cancer is a Department of Health campaign which aims to improve early diagnosis of cancer by raising the public’s awareness of the symptoms of cancer and encouraging people to see their doctor earlier.
The Be Clear on Cancer campaign is the first national Government campaign to raise
awareness of the early signs and symptoms of bowel cancer.
Advertisements featured on national TV, radio and press; there were also online activity and advertising on local buses and public events across the country. The campaign encouraged people who have blood in their poo or loose poo for more than 3 weeks to see their doctor.
Applications of chemically modified synthetic guide RNA for CRISPR-Cas9 genome editingPoster
Our results indicate that MS modifications are required for experiments with co-electroporation of Cas9 mRNA and synthetic gRNA, yet have no impact on editing efficiency when delivered with lipid-based transfection reagents.READ MORE
Highly Accurate HCV Genotyping by Targeted Next Generation SequencingPoster
The recent fast advancement of next generation sequencing (NGS) technologies allowing for unprecedented speed and accuracy in analyzing viral genomes are opening new ways to further improve diagnostic genotyping of HCV.
Inecalcitol Stimulates CD38 Expression in Multiple Myeloma and Acute Myeloid Leukemia Cell LinesPoster
Inecalcitol is a vitamin D receptor agonist currently in Phase II clinical trial in AML (acute myeloid leukemia). Inecalcitol increases the expression of CD38 at the surface of 5 multiple myeloma cell lines; therefore, inecalcitol could potentiate the clinical response of MM patients to a therapeutic anti-CD38 antibody
Inecalcitol induces the expression of the CD38 antigen at the surface of 4 AML cell lines; thus, inecalcitol could render AML patients sensitive to a therapeutic anti-CD38.